- Home
- RYTM vs ASB Comparison
RYTM vs ASB Comparison
Compare RYTM & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- ASB
- Stock Information
- Founded
- RYTM 2008
- ASB 1861
- Country
- RYTM United States
- ASB United States
- Employees
- RYTM N/A
- ASB N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- RYTM Health Care
- ASB Finance
- Exchange
- RYTM Nasdaq
- ASB Nasdaq
- Market Cap
- RYTM 3.5B
- ASB 3.9B
- IPO Year
- RYTM 2017
- ASB N/A
- Fundamental
- Price
- RYTM $56.07
- ASB $24.44
- Analyst Decision
- RYTM Strong Buy
- ASB Hold
- Analyst Count
- RYTM 10
- ASB 9
- Target Price
- RYTM $66.90
- ASB $27.11
- AVG Volume (30 Days)
- RYTM 380.5K
- ASB 1.4M
- Earning Date
- RYTM 02-26-2025
- ASB 01-23-2025
- Dividend Yield
- RYTM N/A
- ASB 3.63%
- EPS Growth
- RYTM N/A
- ASB N/A
- EPS
- RYTM N/A
- ASB 0.72
- Revenue
- RYTM $112,530,000.00
- ASB $952,855,000.00
- Revenue This Year
- RYTM $66.58
- ASB N/A
- Revenue Next Year
- RYTM $44.63
- ASB $5.85
- P/E Ratio
- RYTM N/A
- ASB $34.86
- Revenue Growth
- RYTM 81.55
- ASB N/A
- 52 Week Low
- RYTM $35.17
- ASB $19.76
- 52 Week High
- RYTM $68.58
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- RYTM 42.18
- ASB 43.77
- Support Level
- RYTM $56.03
- ASB $24.62
- Resistance Level
- RYTM $58.65
- ASB $25.60
- Average True Range (ATR)
- RYTM 1.87
- ASB 0.58
- MACD
- RYTM -0.27
- ASB -0.04
- Stochastic Oscillator
- RYTM 5.45
- ASB 24.84
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.